Propanc Biopharma, Inc. (PPCB)
OTCMKTS · Delayed Price · Currency is USD
5.25
-0.25 (-4.55%)
Apr 4, 2025, 2:39 PM EST

Propanc Biopharma Balance Sheet

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Cash & Equivalents
0.010.020.01000.07
Upgrade
Cash & Short-Term Investments
0.010.020.01000.07
Upgrade
Cash Growth
-79.58%109.86%147.04%80.36%-96.64%2698.96%
Upgrade
Other Receivables
000000
Upgrade
Receivables
000000
Upgrade
Prepaid Expenses
000.010.01--
Upgrade
Total Current Assets
0.020.030.020.020.010.07
Upgrade
Property, Plant & Equipment
0.010.020.040.0600.03
Upgrade
Long-Term Deferred Charges
0.050.03----
Upgrade
Other Long-Term Assets
000000
Upgrade
Total Assets
0.080.070.060.080.010.1
Upgrade
Accounts Payable
1.221.210.970.9410.84
Upgrade
Accrued Expenses
1.651.531.210.941.311.06
Upgrade
Short-Term Debt
1.120.870.510.980.681.61
Upgrade
Current Portion of Leases
0.010.020.020.02-0.03
Upgrade
Other Current Liabilities
0.160.160.450.180.090.21
Upgrade
Total Current Liabilities
4.153.793.163.063.083.74
Upgrade
Long-Term Debt
0.080.06----
Upgrade
Long-Term Leases
--0.020.04--
Upgrade
Total Liabilities
4.243.853.183.113.083.74
Upgrade
Common Stock
00.480.0100.010
Upgrade
Additional Paid-In Capital
61.8861.2260.3157.3654.0750.91
Upgrade
Retained Earnings
-67.48-66.7-64.68-61.56-58.2-55.78
Upgrade
Treasury Stock
-0.05-0.05-0.05-0.05-0.05-0.05
Upgrade
Comprehensive Income & Other
1.491.271.291.211.091.27
Upgrade
Total Common Equity
-4.16-3.78-3.12-3.03-3.07-3.65
Upgrade
Shareholders' Equity
-4.16-3.78-3.12-3.02-3.07-3.64
Upgrade
Total Liabilities & Equity
0.080.070.060.080.010.1
Upgrade
Total Debt
1.210.950.551.040.681.63
Upgrade
Net Cash (Debt)
-1.19-0.93-0.54-1.04-0.68-1.57
Upgrade
Filing Date Shares Outstanding
0.020.01----
Upgrade
Working Capital
-4.14-3.77-3.14-3.05-3.07-3.67
Upgrade
Tangible Book Value
-4.16-3.78-3.12-3.03-3.07-3.65
Upgrade
Machinery
-0.030.030.030.030.03
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.